Bright Minds Biosciences Inc.
NASDAQ:DRUG · NASDAQ Capital Market
+$0.62 today
Vol 0.24M · Avg 0.27M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+123.92%
Period High
$95.99
Period Low
$23.27
Latest
$60.66
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
LB Pharmaceuticals Inc Common Stock
NASDAQ:LBRX
$849.60M
Design Therapeutics, Inc.
NASDAQ:DSGN
$758.85M
Annexon, Inc.
NASDAQ:ANNX
$586.61M
Aura Biosciences, Inc.
NASDAQ:AURA
$399.64M
DiaMedica Therapeutics Inc.
NASDAQ:DMAC
$307.56M
Altimmune, Inc.
NASDAQ:ALT
$240.01M
I-Mab
IMAB
$235.66M
Galectin Therapeutics Inc.
NASDAQ:GALT
$183.48M
Korro Bio, Inc.
NASDAQ:KRRO
$125.81M
enGene Holdings Inc.
NASDAQ:ENGN
$87.54M
What is the latest DRUG filing?
The latest filing shown is 6-K dated Jun 3, 2026.
How many recent filings does DRUG have?
Intrinsic Alpha currently shows 20 recent filings for DRUG.
Explore More
Continue the stock analysis
Jump to another research area for this company.